Haemonetics (HAE) Operating Income Growth (3y) (2012 - 2026)
Haemonetics (HAE) Operating Income Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 75.54% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 34.83% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.70% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn | -38.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -38.44% |
| Dec 27, 2025 | 15.91% |
| Sep 27, 2025 | 7.77% |
| Jun 28, 2025 | 20.53% |
| Mar 29, 2025 | 54.88% |
| Dec 28, 2024 | 18.30% |
| Sep 28, 2024 | 28.25% |
| Jun 29, 2024 | 205.82% |
| Mar 30, 2024 | 50.58% |
| Dec 30, 2023 | 4.38% |
| Sep 30, 2023 | -15.63% |
| Jul 1, 2023 | 66.07% |
| Apr 1, 2023 | 10.67% |
| Dec 31, 2022 | 1.90% |
| Oct 1, 2022 | -2.06% |
| Jul 2, 2022 | 62.78% |
| Apr 2, 2022 | -6.98% |
| Jan 1, 2022 | 7.98% |
| Oct 2, 2021 | -2.04% |
| Jul 3, 2021 | -35.96% |